Fulgent Genetics (FLGT) Treasury Shares (2015 - 2025)

Fulgent Genetics has reported Treasury Shares for 11 years, with the latest figure at $2.2 million in Q4 2025.

• Quarterly Treasury Shares rose 1.22% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (up 1.22% YoY) and the FY2025 annual result came in at $2.2 million, up 1.22% from the prior year.
• Treasury Shares grew to $2.2 million in Q4 2025 per FLGT's latest filing, from $2.2 million in the prior quarter.
• Over five years, Treasury Shares peaked at $2.6 million in Q4 2022 and troughed at $1.6 million in Q4 2021.
• A 5-year average of $2.2 million and a median of $2.2 million in 2023 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2021 and 2022: Treasury Shares dropped 22.35% in 2021, then soared 62.51% in 2022.
• Over 5 years, Treasury Shares stood at $1.6 million in 2021, then jumped by 62.51% to $2.6 million in 2022, then dropped by 16.0% to $2.2 million in 2023, then decreased by 0.18% to $2.2 million in 2024, then rose by 1.22% to $2.2 million in 2025.
• According to Business Quant data, Treasury Shares over the past three periods registered $2.2 million, $2.2 million, and $2.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.